(Q45285621)

11 December 2017

title

Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice (English)

1 reference

11 December 2017

1 reference

1 reference

Yoshinori Aono

1 reference

11 December 2017

Yasuhiko Nishioka

1 reference

11 December 2017

Mami Inayama

1 reference

11 December 2017

Momoyo Ugai

1 reference

11 December 2017

Jun Kishi

1 reference

11 December 2017

Hisanori Uehara

1 reference

11 December 2017

Keisuke Izumi

1 reference

11 December 2017

Saburo Sone

1 reference

11 December 2017

language of work or name

English

0 references

publication date

25 February 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

11 December 2017

published in

1 reference

11 December 2017

volume

171

1 reference

11 December 2017

1 reference

11 December 2017

page(s)

1279-1285

1 reference

Idiopathic Pulmonary Fibrosis

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Demystifying idiopathic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Novel PDGF family members: PDGF-C and PDGF-D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Platelet-derived growth factor in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Simple method of estimating severity of pulmonary fibrosis on a numerical scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Rat lung fibroblast collagen metabolism in bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

In vivo gene transfer of an extracellular domain of platelet-derived growth factor beta receptor by the HVJ-liposome method ameliorates bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-531OC

10.1164/RCCM.200404-531OC

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference